In line with these findings, our investigation adds to the understanding of SUMO dynamics by revealing that RANGAP1 undergoes SUMO1 conjugation modification, adding another level of complexity to the intricate landscape of glioma-associated protein modifications. Here, RANGAP1 is linked to central nervous system cancer.